Why Sponsor EADO 2027?
EADO is the most specialized European meeting in dermato-oncology — a compact, high-value audience that translates directly into the therapeutic decision-makers for skin cancer treatments.
Your audience
- Dermato-oncologists, surgical oncologists, medical oncologists, and pathologists
- 1,400+ participants, more than 80 % of them international
- Decision-makers and key opinion leaders in melanoma, keratinocyte carcinomas, Merkel cell carcinoma, and rare skin tumors
Scientific scope
- Immune checkpoint inhibitors, targeted therapies, and neoadjuvant strategies
- Diagnostics, AI-based imaging, dermatoscopy, and confocal microscopy
- Surgery, radiotherapy, supportive care, prevention, and early detection
What sponsors gain
- Direct access to a focused, high-prescriber audience in a single dedicated venue
- Premium satellite symposium slots — Platinum slots run without any parallel program
- Year-round visibility through the post-event on-demand platform
- A flexible configuration in which you pay only for what you need
Pre-Promotion
- Online promotion of the congress via the congress website and online congress calendars
- Promotion via the involved national and international associations and speakers
- Promotion at other international events and congresses related to the area of the 23rd EADO Congress
- Collaboration with various Media Partners
- Mailing of periodical e-newsletters prior to the congress to the target audience
- Production and distribution of promotional and informational materials
- Social Media
Become a Sponsor